36
Participants
Start Date
August 31, 2007
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
Azacitidine
75 mg/m\^2 Subcutaneous Injection or by vein Daily for 5 Days.
Valproic Acid
40 mg/kg by mouth Daily for 7 days.
Carboplatin
AUC 2 by vein on Days 3 and 10 over 60 Minutes.
UT MD Anderson Cancer Center, Houston
Collaborators (1)
Celgene Corporation
INDUSTRY
M.D. Anderson Cancer Center
OTHER